摘要
目的观察血府逐瘀胶囊在冠心病治疗中的应用情况。方法用"双盲法"将80例冠心病患者分为40例/组。对照组-常规西药治疗,观察组-常规西药治疗+血府逐瘀胶囊治疗。比较中医证候积分、血脂水平。结果经过6个月的治疗,观察组各项中医证候积分都低于对照组,血脂方面,HDL-C高于对照组,其余血脂指标都比对照组低(P<0.05)。结论血府逐瘀胶囊可以很好地缓解冠心病患者疾病症状,改善血脂。
Objective To observe the application of Xuefu Zhuyu Capsule in the treatment of coronary heart disease. Methods 80 patients with coronary heart disease were divided into 40 cases/group by "double-blind method". The control group-conventional western medicine treatment, observation group-conventional western medicine treatment + Xuefu Zhuyu capsule treatment. Compare TCM syndrome scores and blood lipid levels. Results After 6 months of treatment, the scores of TCM syndromes in the observation group were lower than those in the control group. In terms of blood lipids, HDL-C was higher than the control group, and the remaining blood lipid indexes were lower than the control group(P<0.05). Conclusion Xuefu Zhuyu Capsule can relieve the symptoms of coronary heart disease patients and improve blood lipids.
引文
[1]郑国华,谌海英.血府逐瘀胶囊治疗冠心病心绞痛随机对照试验的系统评价[J].中医杂志,2012,53(2):117-121.
[2]陈晓敏,马莉,曹树军等.2013年8月血府逐瘀胶囊对冠心病心绞痛患者临床疗效观察[J].医学综述,2014,20(2):331-333.
[3]齐广平.血府逐瘀胶囊治疗冠心病心绞痛的疗效和安全性[J].中国继续医学教育,2015,7(3):249-250.
[4]郭迎华.血府逐瘀胶囊治疗冠心病心绞痛的疗效观察[J].中西医结合心血管病杂志(电子版),2015,3(13):41-41.
[5]王学军,田国祥,詹中群.血府逐瘀胶囊治疗冠心病心绞痛的Meta分析[J].中国循证心血管医学杂志,2016,8(12):1428-1434.
[6]纪文岩,赵坤,迟伟峰.新血府逐瘀软胶囊对冠心病患者血瘀征象及血管内皮炎症的影响[J].中医杂志,2012,53(22):1934-1936.
[7]纪文岩,姜婷.新血府逐瘀软胶囊对冠心病心绞痛患者T细胞亚群比例的影响[J].中国中医基础医学杂志,2017,23(11):1580-1582.
[8]王丽.血府逐瘀胶囊在冠心病患者治疗中的应用研究[J].中国现代药物应用,2015,9(11):172-173.